Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 268,556 shares at $8.32 ($2.2M) on 2020-12-15, disclosed to the SEC on 2020-12-17.
Open-market sale of $2.2M BCRX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.32 | 134,278 | $1.1M | 50.0% |
| 2 | $8.32 | 134,278 | $1.1M | 50.0% |
| Total | $8.32 avg | 268,556 | $2.2M | 100% |
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |